The Technical Analyst
Select Language :
Quanterix Corp [QTRX]

Exchange: NASDAQ Global Market Sector: Healthcare Industry: Medical Devices

Quanterix Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Quanterix Corp is listed at the NASDAQ Exchange

3.71% $16.79

Last updated: 3 jul 2022 - 20:35

TimeZone: America/New_York


FUNDAMENTALS
MarketCap: 619.72 mill
EPS: -1.796
P/E: 0.000
Earnings Date: Aug 03, 2022
SharesOutstanding: 36.91 mill
Avg Daily Volume: 0.348 mill
RATING 2022-07-01
B+
Buy
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profit
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$27.65
(64.66%) $10.86
Date: 2022-07-04
True Range Average
+/- $1.312
( +/- 7.81%)
Range: 15.48 - 18.10
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-06-13 Toloue Masoud Sell 5 564 Common Stock
2022-06-06 Flynn Karen Buy 19 841 Stock Option (right to buy)
2022-06-06 Flynn Karen Buy 13 227 Common Stock
2022-06-02 Fry John J Sell 378 Common Stock
2022-06-02 Hrusovsky E Kevin Sell 712 Common Stock
INSIDER POWER
-0.57
Last 100 transactions
Buy: 429 588 | Sell: 530 100

Forecast: 16:00 - $16.79

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $16.79
Forecast 2: 16:00 - $16.79
Forecast 3: 16:00 - $16.79
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $16.79 (3.71% )
Volume 0.160 mill
Avg. Vol. 0.348 mill
% of Avg. Vol 45.98 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Quanterix Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Quanterix Corp

RSI

Intraday RSI14 chart for Quanterix Corp

Last 10 Buy & Sell Signals For QTRX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since 31-12-69

Date Signal @ Closed %
Jun 29 - 16:20sell$16.71N/AActive
The Live Chart for Quanterix Corp
Profile picture for
            Quanterix Corp

QTRX

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 177 full-time employees. The firm offers single molecule array (Simoa) platform, which uses single molecule measurements to detect protein biomarkers. The firm is also focusing to enable and develop novel therapies and diagnostics to facilitate in healthcare for earlier detection, monitoring, prognosis and, ultimately, prevention of disease. Simoa focuses on research and clinical testing applications and significantly advances enzyme-linked immunosorbent assay (ELISA) technology which is capable of unprecedented protein detection sensitivity. The company also focuses on research and diagnostics for brain injuries, heart disease, cancer and other infectious diseases with its technology. The firm offers Simoa HD-1 analyzer, which is an automated immunoassay platform with multiplexing and custom assay capability.

Last 10 Buy Signals
Date Signal @
PARTUSDJul 3 - 20:300.328
NXSUSDJul 3 - 20:300.137
GNOUSDJul 3 - 20:29111.10
DCRUSDJul 3 - 20:2922.59
USDTUSDJul 3 - 20:290.999
UBQUSDJul 3 - 20:280.0337
LSKUSDJul 3 - 20:271.032
PIVXUSDJul 3 - 20:240.109
PARTUSDJul 3 - 20:240.328
QRLUSDJul 3 - 20:220.177

Stock Peers

Company Price Change
QTRX16.793.71%
BDSI5.59-0.09%
CHRS7.838.15%
CTIC6.081.84%
EGRX46.695.09%
ITOS20.871.31%
NKTX13.186.98%
PMVP15.488.63%
SLN12.001.27%
ZEAL13.091.55%
ZIMV15.88-0.81%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.